PharmaShots | Incisive News in 3 Shots

Subscribe Now

Latigo Biotherapeutics

Latigo Biotherapeutics Reports the First Patient Dosing with LTG-305 in its P-I Study for Non-Opioid Treatment of Pain

Latigo Biotherapeutics Reports the First Patient Dosing with LTG-305 in its P-I Study for Non-Opioid Treatment of Pain

October 17, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us